Alkem Laboratories Q4 net profit up 12% at Rs 191.54 crore
Revenue from operations also rose to Rs 2,048.99 crore for the quarter under consideration as against Rs 1,853.03 crore for the same period year ago, it added.05-06-2020
05-06-2020
Alkem Laboratories Ltd - 539523 - Closure of Trading Window
We refer to our earlier communication dated 17th March, 2020 regarding closure of trading window (for the purpose of financial results for the quarter and year ended 31st March 2020) starting from 30th March, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2020 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and year ended 31st March, 2020 having been communicated to the Stock Exchanges, today i.e. 05th June, 2020, the trading window shall open on 08th June, 2020.05-06-2020
Alkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY20 and FY20 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same05-06-2020
Alkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date
The Board of Directors at its meeting held today i.e. 05th June, 2020 has fixed 11th August, 2020 as the record date for the purposes of the Annual General Meeting and payment of final dividend. Kindly take the same on record.05-06-2020
Alkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividend
The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia: 1. recommended a final dividend of Rs. 3/- (Rupees three only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2020, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. 2. fixed that the 46th Annual General Meeting of the Company shall be held on 18th August, 2020. 2. fixed 11th August, 2020 as the record date for the purposes of the Annual General Meeting and payment of final dividend. The dividend, if declared by the shareholders, shall be paid on and from 21st August, 2020. Kindly take the same on record.05-06-2020
Alkem Laboratories Ltd - 539523 - Results - Financial Results For March 31, 2020.
In continuation of our letter dated 26th May, 2020 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, at its meeting held today, i.e. 05th June, 2020, has inter alia: . 1. Approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2020. Accordingly we e are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2020 and the Auditor''s Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2020. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 2.25 P.M Kindly take the same on record.05-06-2020
Alkem Laboratories Ltd - 539523 - Outcome Of Board Meeting Dated 05Th June 2020
The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia: 1. approved the Standalone and Consolidated Audited Financial Statements of the Company for the quarter and financial year ended 31st March, 2020. 2. recommended a final dividend of Rs. 3/- (Rupees three only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2020, for the approval of the shareholders of the Company at the ensuing Annual General Meeting Accordingly, we are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2020 and the Auditor''s Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2020. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 2.25 p.m.05-06-2020
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY20 and FY20 financial results will be held on Friday, 05th June, 2020 at 4.30 pm. Please find attached herewith the conference call details. Kindly take note of the same.27-05-2020
Alkem Laboratories Ltd - 539523 - Board to consider FY20 results & Final Dividend on June 05, 2020
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 05, 2020, inter alia:1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2020; and2. To consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2020.26-05-2020